1 year return (CAGR)
90.24%
NeuBase Therapeutics Inc Exchange (NASDAQ, USD)
NBSE
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-57.74%
5 year return (CAGR)
-33.52%
10 year return (CAGR)
-46.00%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.42M
Price/Sales
-
Ent value
-1.67M
Price/Book
0.16
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-37.19%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 0.38 |
| Daily high | 0.38 |
| Daily low | 0.38 |
| Daily Volume | 0K |
| 1y analyst estimate | 140.00 |
| Beta | 0.94 |
| EPS (TTM) | -5.19 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NBSE | S&P500 | |
| Current price drop from All-time high | -99.90% | -0.36% |
| Highest price drop | -99.97% | -56.47% |
| Date of highest drop | 26 Apr 2023 | 9 Mar 2009 |
| Avg drop from high | -86.27% | -10.68% |
| Avg time to new high | 110 days | 12 days |
| Max time to new high | 2567 days | 1805 days |
News
No items found